4.3 Article

Stable DNMT3L overexpression in SH-SY5Y neurons recreates a facet of the genome-wide Down syndrome DNA methylation signature

期刊

EPIGENETICS & CHROMATIN
卷 14, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13072-021-00387-7

关键词

DNMT3L; Down syndrome; Whole genome bisulfite sequencing; Bivalent chromatin; Epigenomics; PiggyBac transgenesis

资金

  1. National Institutes of Health (NIH) [3R01ES015359-10S1]
  2. Canadian Institutes of Health Research (CIHR) [MFE-146824]
  3. CIHR Banting postdoctoral fellowship [BPF-162684]
  4. Jane Coffin Childs Memorial Fund for Medical Research fellowship
  5. NIH T32 Fellowship [5T32CA108459]
  6. UC Davis Intellectual and Developmental Disabilities Research Center (IDDRC) [P50HD103526]
  7. UC Davis Comprehensive Cancer Center Support Grant (CCSG) - National Cancer Institute [NCI] [P30CA093373]
  8. NIH Shared Instrumentation Grant [1S10OD010786-01]

向作者/读者索取更多资源

This study demonstrated that overexpression of the chromosome 21 gene DNMT3L led to global hypermethylation of CpG sites and CpG islands, as well as thousands of differentially methylated regions (DMRs) mapped to genes involved in neurodevelopment and gene regulation. The overexpressed DNMT3L also affected the clustering of cell lines based on genotype and differentiation phase, targeting genes across neuronal differentiation. Hypermethylated DMRs were enriched for bivalent chromatin regions marked by H3K4me3, while hypomethylated DMRs showed a tissue-specific profile enriched for heterochromatin regions marked by H3K9me3 during embryonic development, recreating a facet of the genome-wide DS DNA methylation signature.
Background Down syndrome (DS) is characterized by a genome-wide profile of differential DNA methylation that is skewed towards hypermethylation in most tissues, including brain, and includes pan-tissue differential methylation. The molecular mechanisms involve the overexpression of genes related to DNA methylation on chromosome 21. Here, we stably overexpressed the chromosome 21 gene DNA methyltransferase 3L (DNMT3L) in the human SH-SY5Y neuroblastoma cell line and assayed DNA methylation at over 26 million CpGs by whole genome bisulfite sequencing (WGBS) at three different developmental phases (undifferentiated, differentiating, and differentiated). Results DNMT3L overexpression resulted in global CpG and CpG island hypermethylation as well as thousands of differentially methylated regions (DMRs). The DNMT3L DMRs were skewed towards hypermethylation and mapped to genes involved in neurodevelopment, cellular signaling, and gene regulation. Consensus DNMT3L DMRs showed that cell lines clustered by genotype and then differentiation phase, demonstrating sets of common genes affected across neuronal differentiation. The hypermethylated DNMT3L DMRs from all pairwise comparisons were enriched for regions of bivalent chromatin marked by H3K4me3 as well as differentially methylated sites from previous DS studies of diverse tissues. In contrast, the hypomethylated DNMT3L DMRs from all pairwise comparisons displayed a tissue-specific profile enriched for regions of heterochromatin marked by H3K9me3 during embryonic development. Conclusions Taken together, these results support a mechanism whereby regions of bivalent chromatin that lose H3K4me3 during neuronal differentiation are targeted by excess DNMT3L and become hypermethylated. Overall, these findings demonstrate that DNMT3L overexpression during neurodevelopment recreates a facet of the genome-wide DS DNA methylation signature by targeting known genes and gene clusters that display pan-tissue differential methylation in DS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据